PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Bioscientia Labor Ingelheim, Konrad-Adenauer-Straße 17, 55218 Ingelheim, Germany.\', \'Department of Medical Microbiology and Hygiene, Saarland University, Kirrbergerstr. 100 Geb. 43, 66421 Homburg/Saar, Germany. Electronic address: barbara.gaertner@uks.eu.\', \'Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Peter-Mayr-Str. 4b, 6020 Insbruck, Austria.\', \'Department of Trauma Surgery, University Medical Centre Regensburg, Franz-Josef-Strauss Allee 11, 93053, Regensburg, Germany.\', \'Institute of Sports and Preventive Medicine, Saarland University, Campus, Geb. B8.2 66123 Saarbrücken, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1198-743X(20)30729-110.1016/j.cmi.2020.11.033
?:hasPublicationType
?:journal
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33285279
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May-June 2020): implications for a testing protocol in asymptomatic individuals and estimation of the rate of undetected cases.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all